These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6306780

  • 1. [Biochemistry and pharmacology of benzamides].
    Boyer P.
    Sem Hop; 1983 Mar 24; 59(12):832-5. PubMed ID: 6306780
    [Abstract] [Full Text] [Related]

  • 2. The mode of action of sulpiride as an atypical antidepressant agent.
    Jenner P, Marsden CD.
    Adv Biochem Psychopharmacol; 1982 Mar 24; 32():85-103. PubMed ID: 7046370
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS, Runice C, Dowd F.
    J Pharmacol Exp Ther; 1984 Apr 24; 229(1):32-7. PubMed ID: 6323689
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
    Memo M, Missale C, Carruba MO, Spano PF.
    J Neural Transm Suppl; 1986 Apr 24; 22():19-32. PubMed ID: 2431109
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME, Bernabei A, Treisman G.
    J Pharmacol Exp Ther; 1983 Mar 24; 224(3):627-33. PubMed ID: 6827485
    [Abstract] [Full Text] [Related]

  • 8. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 24; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 24; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 12. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN, Jenner P, Huizing G, Marsden CD, Miller R.
    Neuropharmacology; 1977 May 24; 16(5):333-42. PubMed ID: 559256
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
    Usuda S, Nishikori K, Noshiro O, Maeno H.
    Psychopharmacology (Berl); 1981 May 24; 73(2):103-9. PubMed ID: 6112770
    [Abstract] [Full Text] [Related]

  • 14. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW, Tsuruta K, Cote TE, Grewe CW.
    Adv Biochem Psychopharmacol; 1982 May 24; 35():17-49. PubMed ID: 6293277
    [No Abstract] [Full Text] [Related]

  • 15. [Antiemetic activity of dimetpramid].
    Legeza VI, Shagoian MG, Martirosov KS, Kamynina MF, Markovskaia IV.
    Farmakol Toksikol; 1984 May 24; 47(5):55-9. PubMed ID: 6542025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
    Jenner P, Marsden CD.
    Acta Psychiatr Scand Suppl; 1984 May 24; 311():109-23. PubMed ID: 6142587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of chronic treatment with l-sulpiride and haloperidol on central monoaminergic mechanisms.
    Fuxe K, Ogren SO, Hall H, Agnati LF, Andersson K, Köhler C, Schwarcz R.
    Adv Biochem Psychopharmacol; 1980 May 24; 24():193-206. PubMed ID: 6967676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.